Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
CRXT CLARUS THERAPEUTICS HLDGS INC
0.0480.0000.00%
Close
09/06 16:00 ET
High
0.000
Open
0.000
Turnover
0.00
Low
0.000
Pre Close
0.048
Volume
0.00
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Clarus Therapeutics Holdings, Inc. Announces Completion of Auction for Sale of JATENZO® and Selection of Tolmar, Inc. as Successful Bidder
Court-supervised auction for JATENZO (testosterone undecanoate capsules; C-III) concluded on October 14, 2022 NORTHBROOK, Ill., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (
Testosterone Drug Maker Clarus Files For Bankruptcy -- Market Talk
1534 ET - Publicly traded Clarus Therapeutics Holdings, the maker of testosterone drug Jatenzo, has filed for chapter 11 bankruptcy, saying it has missed its sales targets and been unable to meet its
Clarus Files for Chapter 11 Bankruptcy, Eyes Auction of Testosterone Therapy Jatenzo
Clarus Therapeutics (OTCPK:CRXT) filed voluntary petitions under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware and want to pursue an auction and sale of its only commercial asse
Clarus Therapeutics: Jatenzo Auction Projected to End in Late October >CRXT
Clarus Therapeutics: Jatenzo Auction Projected to End in Late October >CRXT
Clarus Therapeutics Seeks Authorization to Pursue Auction, Sale Process for Sole Commercial Asset Jatenzo >CRXT
Clarus Therapeutics Seeks Authorization to Pursue Auction, Sale Process for Sole Commercial Asset Jatenzo >CRXT
Clarus Therapeutics Files Voluntary Petitions Under Chapter 11 >CRXT
Clarus Therapeutics Files Voluntary Petitions Under Chapter 11 >CRXT
Clarus Therapeutics Holdings, Inc. Announces Plan for Near-Term Sale of JATENZO® Using Structured Process Through Chapter 11 of the U.S. Bankruptcy Code
Bidding process and auction for JATENZO (testosterone undecanoate capsules; C-III) projected to conclude late October 2022NORTHBROOK, Ill., Sept. 05, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Hol
Why IN8bio Is Trading Higher By 46%, Here Are 54 Stocks Moving In Tuesday's Mid-Day Session
Gainers NewAge, Inc. (NASDAQ:NBEV) rose 54.4% to $0.3220.IN8bio, Inc. (NASDAQ:INAB) jumped 46% to $2.89 after a Form 4 Filing showed Cavu Advisors purchased 51,214 shares at an average price of $2.02.
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 250 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows: Toyota Motor (NYSE:TM) was the biggest company on a market cap basis to set a new 52-week low.SciSparc (N
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
InvestorPlace - Stock Market News, Stock Advice & Trading Tips It's time for another breakdown of the biggest pre-market stock movers as we go over the latest news on Tuesday morning. The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.
